A small randomised study compared PN injections, fractional laser and their combination for longstanding abdominal stretch marks, with encouraging but preliminary results.
A small split-face trial found higher satisfaction when Profhilo was added to subcision, but no significant advantage in objective scar reduction or ultrasound-measured scar depth.
A small randomised trial tested topical polynucleotides after radiofrequency microneedling for melasma, but found no significant added benefit over the device treatment alone.
Upper-lip lines can reflect movement, sun-related skin change and loss of support. Treatment around the mouth may soften movement-related lines, but it can also temporarily affect everyday lip function.
A recent review found encouraging short-term results for periorbital polynucleotides, but one large trial was subsequently retracted, changing how confidently the evidence should be described.
A 2026 pilot reported less visible facial pores after two sessions, but its ten participants, lack of a control group and photographic assessments cannot prove how much change Profhilo caused.
A 2026 study found broadly comparable short-term skin measurements with intradermal and subdermal polynucleotide delivery, but injection depth is not a simple choice between visible bumps and no downtime.
A wider lower face is not always caused by large masseter muscles, and reducing muscle activity can affect chewing as well as contour. Assessment should separate aesthetic goals from dental or jaw-joint problems.
Laboratory studies can show collagen-related activity, but this is not the same as proving that an injectable polynucleotide will create a visible or lasting improvement for every patient.
A small uncontrolled study reported changes in abdominal skin measurements after two sessions, but Profhilo Body cannot remove fat, repair separated muscles or replace surgery for substantial excess skin.
Research on established depressed scars and early postoperative scars uses different products and treatment timings, so the findings cannot be combined into one standard polynucleotide scar protocol.
Forehead lines can be part of the way the forehead helps lift the eyebrows or eyelids, so relaxing every visible line may worsen heaviness rather than improve it.
A small uncontrolled study reported increased hair density and diameter after scalp polynucleotide injections, but diagnosis and established treatment options still come first.
A small single-centre study reported changes in hand skin measurements after Profhilo Body, but it had no comparison group and cannot show how much visible improvement an individual will notice.
Some injectable products combine polynucleotides with hyaluronic acid, so results from a hybrid formulation cannot be attributed to polynucleotides alone or applied to every product.
Research shows average anatomical differences between male and female foreheads, but sex alone cannot determine a safe or appropriate anti-wrinkle treatment plan.
A 2026 observational study reported improvement in dark-circle severity after three polynucleotide sessions, but its open-label design cannot prove how much change came from the treatment itself.
A small 2026 study found no additional short-term improvement in forehead wrinkles or ultrasound measurements when Profhilo was added to an anti-wrinkle treatment.
A small split-face trial suggests that one adjusted polynucleotide formulation may reduce injection pain, but comfort varies and the result cannot be applied to every product or treatment area.
Lower-face muscles work together during smiling, speaking and eating. New evidence shows why treatment extent, anatomy and function matter more than choosing a package by its number of areas.
Facial redness has many possible causes. A two-patient report suggests that a combined polynucleotide and hyaluronic acid injectable deserves further study, but it does not establish a treatment for rosacea or persistent erythema.
A 12-month study followed repeated Profhilo Body treatment for inner upper-arm skin laxity, but its single-arm design and intensive schedule limit what can be promised from a routine course.
A small randomised trial measured changes in pore volume and texture after polynucleotide injections, but it does not prove that every visible pore will respond or identify the best treatment for every cause.
Good aftercare separates sensible precautions from rigid rules, explains expected short-term reactions and gives every patient a clear route to help if concerning symptoms develop.
A small study has examined polynucleotide injections for dry, rough lips, but the early findings do not prove that injections are better than appropriate lip care or treatment of an underlying cause.
A recent small trial examined Profhilo around the mouth, but perioral lines have several causes and the treatment should not be presented as a substitute for lip filler or movement-relaxing treatment.
Early research suggests polynucleotides may support recovery after some energy-based procedures, but one small study cannot establish the best approach for every patient.
Starting anti-wrinkle treatment before lines are deeply established is sometimes described as preventative, but the long-term evidence is limited and treatment is not a guarantee against facial ageing.
Polynucleotides may be considered for selected skin-quality concerns on the neck and upper chest, but they cannot lift substantial laxity, remove sun damage or treat every visible line.
Small bumps, redness and tenderness can occur after Profhilo, but aftercare should also explain what is not expected and how to obtain prompt clinical advice.
Early research suggests a possible role for polynucleotides in selected atrophic acne scars, but one injectable cannot treat every scar type or replace control of active acne.
A result that feels weaker than expected is not automatically treatment resistance. Timing, the original concern, facial movement and the treatment record all need a careful review before any next step.
PN and PDRN are both DNA-derived materials, but the labels do not describe identical products. Understanding the difference helps patients ask better questions about formulation, evidence and suitability.
Profhilo is not a guaranteed same-day glow treatment. Planning well before a wedding, holiday or celebration allows time for assessment, a treatment course, downtime and an honest review of the result.
Polynucleotides and dermal fillers are both injectable treatments, but they are chosen for different concerns. Understanding the distinction helps set realistic goals for skin quality, volume and facial contour.
A line that appears only during expression is different from one visible when the face is relaxed. Understanding that difference helps set realistic goals for prescription-only anti-wrinkle treatment.
Small bumps, redness, swelling or bruising may be visible after polynucleotide injections. Knowing what is expected, what needs review and why aftercare varies helps you plan treatment more safely.
The neck often shows dryness, fine lines and reduced elasticity, but not every concern has the same cause. This guide explains where Profhilo may fit, what it cannot correct and what to expect after treatment.
Menopause can coincide with drier, thinner-feeling skin and changes in texture. Polynucleotides may support selected skin-quality concerns, but they are not a treatment for menopause and expectations should remain measured.
Most faces are not perfectly symmetrical, especially during expression. Recognising your natural differences before anti-wrinkle treatment helps create a safer, more realistic and personalised plan.
Polynucleotide treatment is usually planned as a course rather than a one-off appointment. Understanding the timeline helps you judge subtle skin-quality changes realistically and plan around possible downtime.
Profhilo is often grouped with dermal fillers because both contain hyaluronic acid, but they are selected for different concerns. Here is a practical guide to the expected changes, limitations and treatment journey.
Under-eye concerns can come from thin skin, pigment, blood vessels, hollowness or puffiness. Understanding the cause is the first step in deciding whether polynucleotides may help.
A careful consultation is about much more than counting treatment areas. It is where your health, facial movement, goals and alternatives are assessed together.